April 23, 2024 12:31 (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Rajnath Singh visits Siachen, carries out assessment of security situation | Government employee shot dead in targeted attack in Kashmir's Rajouri | 'Congress will take away your homes, jewels': PM Modi ups his attack amid row | Centre orders sampling test of spices from Everest, MDH after ban in Hong Kong, Singapore | 'Illegal, I challenge it': Mamata Banerjee on Calcutta HC cancelling 24,000 jobs in SSC scam probe
India-made Biological E's vaccine likely to be 90 pc effective; could be game-changer in fight against pandemic : Expert Biological E | Corbevax
Image: Unsplash

India-made Biological E's vaccine likely to be 90 pc effective; could be game-changer in fight against pandemic : Expert

India Blooms News Service | @indiablooms | 17 Jun 2021, 07:09 pm

New Delhi/IBNS: Indigenously-made Biological E's anti-Covid19 jab, expected to have an efficacy of 90 per cent could be a gamechanger in the battle against the pandemic, according to a top doctor on a government advisory panel.

Dr NK Arora, chairperson of the centres Covid Working Group, said the vaccine will now undergo third phase of clinical trials and could be available for inoculation by October, according to an NDTV report.

"Novavax (of Serum Institute) is very exciting. In the past week it has created a rage because India is going to manufacture almost a billion doses a year. It is going to be simple and cheaper with a 90 per cent vaccine effectiveness," Dr Arora, who is also the Chairperson of the National Technical Advisory Group on Immunisation (NTAGI) which guides the government on matters related to vaccination, told NDTV.

"A very similar Indian vaccine is also under phase 3 trial, which is the Bio E vaccine. These vaccines are exciting because we have previous experience on a similar platform. They are safe across the age groups and have very high effectiveness," he said.

The vaccine will be called Corbevax, and is similar to Novavax vaccine, which, according to its maker, is 90 per cent effective against coronavirus, including its variants.

Bio E's vaccine may hold huge potential as it is likely to be available just at Rs 250 for two doses.

The other two vaccines that were mentioned by Dr Arora are Zydus-Cadila's product and other indegenous vaccine based on messenger-RNA Covid vaccine to be manufactured by Gennova Biopharmaceuticals.

Indian m-RNA vaccine is currently in phase 2 trial and likely to be available by September, he said, adding that it is more compatible with Indian conditions-- storage, transport and shelf life.

India's battery of affordable and effective Covid-19 vaccines could be a major help in combating the pandemic and there is a strong chance that the world would have to ultimately depend on us, he said.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.